Related Experiment Video
Updated: Jan 30, 2026
09:39
Assessing Specificity of Anticancer Drugs In Vitro
Published on: March 23, 2016
9.8K
Peptide Sequence-Dominated Enzyme-Responsive Nanoplatform for Anticancer Drug Delivery
Yanan Li1, Liping Du2, Chunsheng Wu2
1First Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
Current Topics in Medicinal Chemistry
|January 29, 2019
Summary
Enzyme-responsive nanomaterials offer advanced tumor diagnostics and targeted drug delivery by exploiting changes in the tumor microenvironment. This review explores enzyme-triggered nanostructures for enhanced cancer treatment strategies.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Enzymatic dysregulation in tumor microenvironments is a key factor in cancer progression.
- Enzyme-responsive drug delivery systems (DDSs) leverage these enzymatic changes for targeted therapies.
- Nanotechnology integration has significantly advanced enzyme-responsive DDSs.
Purpose of the Study:
- To review changes in tumor and intracellular microenvironmental factors, focusing on the enzymatic index.
- To summarize peptide sequences of enzyme-triggered nanomaterials for drug delivery applications.
- To discuss other enzyme-responsive nanostructures and future opportunities in targeted cancer therapy.
Main Methods:
- Review of current literature on enzyme-responsive nanomaterials and their applications.
- Analysis of enzymatic dysregulation in tumor microenvironments.
- Summarization of peptide sequences and nanostructures for drug delivery.
Main Results:
- Enzyme-responsive nanomaterials show promise for diagnostics, carrier targeting, and drug release.
- Various enzyme-triggered peptide sequences and nanostructures are effective in drug delivery.
- Exploiting internal enzyme stimuli offers potential for targeted tumor diagnosis and treatment.
Conclusions:
- Enzyme-responsive nano-drug delivery systems (nanoDDSs) represent a promising frontier in oncology.
- Further research into enzyme stimuli-responsive nanoDDSs can inspire novel targeted tumor diagnosis and treatment strategies.
- Addressing future opportunities and challenges will optimize the clinical translation of these advanced DDSs.
More Related Videos
Related Concept Videos
02:43Peptide Bonds
82.8K
A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
82.8K
01:43Incomplete Dominance
30.0K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
30.0K
01:16Drug Delivery: Overview
843
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
843
01:18Drug Delivery: Enteral Route
1.7K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.7K
01:29Drug Delivery: Parenteral Route
1.7K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.7K
01:22Drug Delivery: Miscellaneous Routes
813
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
813